Weight loss medication,
personalized to you

The process has three steps. First, you complete a confidential medical intake covering your health history, current medications, and weight management goals. Second, a licensed provider in your state reviews your information — typically within 24 to 48 hours — and, if clinically appropriate, issues a prescription. Third, your medication ships directly from a licensed US compounding pharmacy in discreet, temperature-controlled packaging. Ongoing care, dose adjustments, and provider messaging are included in your monthly plan.

Start with a short online questionnaire and, if appropriate, a video or message-based visit with a licensed clinician. If they determine semaglutide is suitable, they send a prescription to a partner pharmacy that ships medication to you.

Adults with obesity or overweight with a weight-related condition may be candidates when a clinician agrees benefits outweigh risks. Semaglutide is not for everyone; personal and family history, medications, and lab findings all factor into eligibility.

Semaglutide for weight management is typically a once-weekly subcutaneous injection using a small pen or syringe. Your clinician or pharmacist materials explain injection sites, rotation, storage, and how to follow the titration schedule they prescribe.

Common effects can include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose increases. Serious risks exist; read FDA-approved labeling and your personalized plan, and contact a clinician promptly for severe or persistent symptoms.

No medication replaces nutrition, movement, sleep, and follow-up care. GLP-1 therapies can support meaningful weight change for many people when combined with lifestyle coaching and monitoring, but individual results vary and long-term success depends on adherence and medical oversight.

Semaglutide Miami refers to medically supervised weight-loss programs in the Miami area that may prescribe semaglutide as part of a broader plan. The medication mimics GLP-1 to reduce appetite and food intake; your clinician sets dosing, monitors progress, and adjusts care over time.